Metastasis awakening: the challenges of targeting minimal residual cancer

Nat Med. 2013 Mar;19(3):274-5. doi: 10.1038/nm.3121.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Chemotherapy, Adjuvant
  • Drug Resistance, Neoplasm*
  • Humans
  • Molecular Targeted Therapy
  • Neoplasm Metastasis / drug therapy
  • Neoplasm Metastasis / pathology*
  • Neoplasm, Residual / drug therapy*
  • Neoplasm, Residual / pathology*
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Neoplastic Cells, Circulating / drug effects*
  • Neoplastic Cells, Circulating / pathology
  • Treatment Outcome

Substances

  • Antineoplastic Agents